Colestilan

Jump to: navigation, search
Colestilan
Colestilan.png
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC7H11ClN2O
Molar mass174.62 g/mol
3D model (JSmol)

WikiDoc Resources for Colestilan

Articles

Most recent articles on Colestilan

Most cited articles on Colestilan

Review articles on Colestilan

Articles on Colestilan in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Colestilan

Images of Colestilan

Photos of Colestilan

Podcasts & MP3s on Colestilan

Videos on Colestilan

Evidence Based Medicine

Cochrane Collaboration on Colestilan

Bandolier on Colestilan

TRIP on Colestilan

Clinical Trials

Ongoing Trials on Colestilan at Clinical Trials.gov

Trial results on Colestilan

Clinical Trials on Colestilan at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Colestilan

NICE Guidance on Colestilan

NHS PRODIGY Guidance

FDA on Colestilan

CDC on Colestilan

Books

Books on Colestilan

News

Colestilan in the news

Be alerted to news on Colestilan

News trends on Colestilan

Commentary

Blogs on Colestilan

Definitions

Definitions of Colestilan

Patient Resources / Community

Patient resources on Colestilan

Discussion groups on Colestilan

Patient Handouts on Colestilan

Directions to Hospitals Treating Colestilan

Risk calculators and risk factors for Colestilan

Healthcare Provider Resources

Symptoms of Colestilan

Causes & Risk Factors for Colestilan

Diagnostic studies for Colestilan

Treatment of Colestilan

Continuing Medical Education (CME)

CME Programs on Colestilan

International

Colestilan en Espanol

Colestilan en Francais

Business

Colestilan in the Marketplace

Patents on Colestilan

Experimental / Informatics

List of terms related to Colestilan

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Colestilan (INN, trade name BindRen) is a medication that acts as a phosphate binder[1] and bile acid sequestrant.

Clinical Use

Colestilan is used for the treatment of hyperphosphataemia (too high phosphate concentrations in the blood serum) in patients undergoing dialysis, including peritoneal dialysis.[1][2]

Contraindications

Colestilan is contraindicated in patients with bowel obstruction.[2]

Interactions

The substance can inhibit the resorption of other drugs, as well as fat soluble vitamins (A, D, E, K) and folate, from the gut.[1] Resulting lower blood levels can be clinically problematic with immunosuppressant and antiepileptic drugs.[2]

Adverse Effects

Adverse effects include gastrointestinal problems such as constipation, as well as vitamin and calcium deficiency. Vitamin K deficiency sometimes causes gastrointestinal bleeding.[1][2]

Chemistry and Mechanism of Action

Colestilan is a cross-linked copolymer of 2-methylimidazole and epichlorohydrin and works as an anion exchanger resin with affinity to phosphate, bile acid anions and urate. It binds these anions in the gut and removes them from the enterohepatic circulation. Colestilan is not absorbed from the gut, but is excreted together with the bound anions.

References

  1. 1.0 1.1 1.2 1.3 A. Klement (11 November 2013). "Dialysepflichtig – weniger Phosphat mit BindRen". Österreichische Apothekerzeitung (in German) (23/2013): 28f.
  2. 2.0 2.1 2.2 2.3 Haberfeld, H, ed. (2013). Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag.

Linked-in.jpg